SCHEMBL14467952

SCHEMBL14467952

CC1=CC(C=O)C(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14155641 0.67 — —
SCHEMBL12238849 0.67 — —
SCHEMBL24303326 0.67 — —
SCHEMBL5161259 0.64 — —
SCHEMBL15116990 0.63 — —
SCHEMBL8718259 0.60 FUCA1 (0.39) —
SCHEMBL9961616 0.60 FUCA1 (0.39) —
SCHEMBL16381869 0.57 — —
SCHEMBL7051198 0.57 — —
SCHEMBL27647012 0.57 TAS2R46 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007076070-A2 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-07-05 — — WO disclosed
CN-1589271-A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function BRISTOL MYERS SQUIBB CO (US) 2005-03-02 — — CN disclosed
Send feedback